Investigation of the Efficacy of Blood Flow Restricted Training in Lateral Elbow Tendinopathy (NCT06001944) | Clinical Trial Compass
UnknownNot Applicable
Investigation of the Efficacy of Blood Flow Restricted Training in Lateral Elbow Tendinopathy
Turkey (Türkiye)69 participantsStarted 2023-04-11
Plain-language summary
The investigators believe that blood flow-restricted training can result in increased caste hypertrophy and strength without stressing the tendon in lateral elbow tendinopathy, and that changes in local metabolic activities can be effective in the process of tendon healing. The researchers' aim in the study is to investigate the effectiveness of blood flow restriction training in lateral elbow tendinopathy for 8 weeks, in addition to the 2 days a week multi-modal physiotherapy program, which will be applied by limiting blood flow by 40-50% occlusion recommended for the upper extremity using the patient's systolic pressure to the severity of 20-30% of 1 maximum repetition, 75 repetitions including 30-15-15-15 repetitions and 30 seconds rest period between sets, remaining attached to the recommended 10-15 minutes period for the top extremity.
Who can participate
Age range
18 Years – 65 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Between 18 and 65 years of age,
* Lateral tendinopathy diagnosis,
* Have scored 33 or more out of 100 on the Patient Based Tennis elbow Assessment Test (PRTEE).
Exclusion Criteria:
* Dysfunction in the shoulder, neck and/or chest area,
* Local or generalized arthritis.
* The neurological deficit.
* Radial dysfunction,
* Limitation of arm functions,
* A history of shoulder or upper extremity pathology requiring surgery or treatment;
* Venous thromboembolism
* Inflammation or other hematological disorders.
* Coronary artery disease,
* Peripheral arterial disease or hypertension (systolic/diastolic blood pressure \>140 mm Hg/90 mmHg),
* To be pregnant,
* Irritation of median nerves.
* Irritation of radial nerves.
* Irritation of the ulnar nerves,
* The pain score is less than 30 mm.
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Visual Analog Scale
Timeframe: Evaluation should be carried out at baseline, at the end of four weeks of the treatment, at the end of eight weeks of the treatment, and at the end of four weeks of follow-up
2
Painless Grip Strength
Timeframe: Evaluation should be carried out at baseline, at the end of four weeks of the treatment, at the end of eight weeks of the treatment, and at the end of four weeks of follow-up
3
Patient-rated tennis elbow evaluation (PRTEE)
Timeframe: Evaluation should be carried out at baseline, at the end of four weeks of the treatment, at the end of eight weeks of the treatment, and at the end of four weeks of follow-up